Regency Centers Corporation reported that director C. Ronald Blankenship has informed the company he will not stand for re-election and will retire from the Board of Directors. His retirement will be effective at the end of his current term, immediately following the company’s 2026 Annual Meeting of Shareholders.
The company states that Mr. Blankenship’s decision is not due to any disagreement regarding operations, policies, or practices. The Board and management expressed deep appreciation for his 25 years of service and highlighted his leadership, business judgment, and counsel to the organization.
Regency Centers director C. Ronald Blankenship received 481 shares of common stock on February 4, 2026, coded as an acquisition. A footnote explains this represents director fees paid in stock under Regency’s Omnibus Incentive Plan. Following this award, he directly owns 112,351 common shares.
Regency Centers director Peter Linneman reported a routine stock-based compensation transaction. On February 4, 2026, he acquired 357 shares of common stock coded as an "A" (award) transaction. These shares represent director’s fees paid in stock under Regency’s Omnibus Incentive Plan. Following this award, he beneficially owns 53,600 shares of Regency Centers common stock held directly.
Regency Centers Corp director Karin Klein reported a stock-based compensation grant. On February 4, 2026, she acquired 428 shares of Regency Centers common stock, reported at a price of $0.00 per share, as director fees paid in stock under Regency's Omnibus Incentive Plan.
Following this grant, Klein beneficially owns 23,198 shares of Regency Centers common stock in direct ownership form. The filing reflects a routine equity compensation award rather than an open-market purchase or sale.
Regency Centers Corporation executive Nicholas Andrew Wibbenmeyer, West Regional President & CIO, reported an equity grant on a Form 4. He received 4,414 shares of restricted stock on February 3, 2026 at a stated price of $0 per share.
The filing shows he now beneficially owns 4,414 derivative securities, held directly. According to the footnote, these restricted shares vest 25% per year beginning February 3, 2027, meaning the award becomes earned gradually over four years.
Regency Centers Corp. executive Alan Todd Roth, Eastern Regional President and Chief Operating Officer, reported an equity award in the form of a restricted stock grant. On February 3, 2026, he received 4,414 restricted shares of common stock at a price of $0 per share, held directly.
The award is subject to a time-based vesting schedule. According to the footnote, the shares vest 25% per year beginning February 3, 2027, meaning the grant becomes fully vested over four years if the conditions are met.
Regency Centers Corp executive vice president and chief financial officer Michael J. Mas reported receiving a restricted stock grant of 5,601 derivative securities on February 3, 2026. These shares vest 25% annually beginning on February 3, 2027. Following this grant, he beneficially owns 5,601 shares directly.
Regency Centers Corp disclosed that Executive Chairman and director Martin E. Stein Jr. received a grant of 2,069 shares of restricted stock on February 3, 2026. The award was granted at a price of $0 per share and is held directly.
The restricted shares are scheduled to vest in four equal installments of 25% per year, beginning on February 3, 2027. Following this grant, Stein beneficially owns 2,069 derivative securities linked to Regency Centers common stock.
Regency Centers Corp. reported a new equity award to its President and CEO, Lisa Palmer. On February 3, 2026, she received a restricted stock grant covering derivative securities tied to 17,934 shares of common stock at a price of $0 per share.
The filing notes these shares vest in stages, with 25% of the award vesting each year beginning on February 3, 2027. The grant is held directly by Palmer and represents stock-based compensation that increases her beneficial ownership as the shares vest over time.